MedPath

Intermittent Catheterisation on the Bladder Mucosa of Healthy Volunteers With a Micro Hole Zone Catheter

Not Applicable
Completed
Conditions
Urinary Incontinence
Interventions
Device: Comparator
Device: Nautilus Catheter
Registration Number
NCT05224544
Lead Sponsor
Coloplast A/S
Brief Summary

This investigation is a randomized, single-blinded, parallel, single-center investigation. In total, up to 50 subjects (40 completers) will be included and each subject will have two test visits overseen by the Principal Investigator (PI), or designee. Each subject will be enrolled in the investigation, which can be up to 3 days (if Day 0 and Day 1 are not on same day). The subjects will be randomly assigned to test either the test product or the comparator product, with at least 20 subjects assigned to each product.

Detailed Description

This investigation is a randomized, single-blinded, parallel, single-center investigation. Up to 50 subjects (40 completers) will be included and each subject will have two test visits overseen by the Principal Investigator (PI), or designee. Each subject will be enrolled in the investigation, which can be up to 3 days (if Day 0 and Day 1 are not on same day). The subjects will be randomly assigned to test either the test product or the comparator product, with at least 20 subjects assigned to each product. The subjects will undergo cystoscopy and catheterization.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
43
Inclusion Criteria
  1. Has given written informed consent
  2. Is at least 18 years and have full legal capacity
  3. Is female
  4. Has a negative urine Multistix dipstick test for erythrocytes (haematuria)
Exclusion Criteria
  1. Has used an internal urinary catheter or cystoscopy within the past month
  2. Has prior history of bladder surgery
  3. Is symptomatic and/or on medication for overactive bladder
  4. Has evidence of ongoing, active, symptomatic urinary tract infection (UTI) (assessed by PI, or delegate)
  5. Is pregnant and/or breast-feeding
  6. Is participating in other clinical investigations during this investigation
  7. Is menstruating during study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Comparator CatheterComparatorHealthy volunteers to test the comparator.
Test CatheterNautilus CatheterHealthy volunteers to test the investigational intermittent catheter.
Primary Outcome Measures
NameTimeMethod
Change in Appearance of the Bladder Mucosa (βˆ†=Pre-catheterisation at Baseline and Post-catheterization and Visit 2) Rated on a 4-point Scale.2 days

Change in appearance of the bladder mucosa (βˆ†=pre-catheterisation at baseline and post-catheterization and visit 2) rated on a 4-point scale.

The 4-point scale defined as such:

1. no lesions evident;

2. minor mucosal and blood vessel lesions;

3. major blood vessel lesions, and

4. major mucosal and blood vessel lesions,

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

American Health Research

πŸ‡ΊπŸ‡Έ

Charlotte, North Carolina, United States

Β© Copyright 2025. All Rights Reserved by MedPath